The roles of cocoa powder in the treatment of steroid induced hypertension in pediatric patients with atutoimmune diseases

Not Applicable

• Conditions: Pediatric autoimmune diseases receiving steroid treatment; autoimmune diseases; steroid induced hypertension

• Registration Number: TCTR20200804007
• Lead Sponsor: Ramathibodi Hospital Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-04
• Study Completion: 2021-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Pediatric autoimmune diseases requiring steroid with hypertension

Exclusion Criteria

History of glomerulonephritis
Allergic to cocoa powder
Severe hypertension

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcomes of blood pressure reduction of cocoa powder 30 days Blood pressure reduction,

Secondary Outcome Measures

Name	Time	Method
Effect of cocoa powder on reduction of inflammation in autoimmune diseases 30 days ESR